Phase 2 debris cleanup underway in Eaton Fire zone
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...
Debris removal has started at two elementary schools destroyed in the Eaton Fire. Goodman, 72, has put his stunning New ...
Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...
LUFKIN, Texas (KTRE) - Crews were preparing for the second phase of the Daniel McCall Dr. Reconstruction Project. Phase two ...
Parkersburg WTAP-TV on MSN2d
Renovations enter Phase 2 for Southwood Park’s waterslide facilityPARKERSBURG, W.Va. (WTAP) - The City of Parkersburg declared that renovations to the waterslide at Southwood park are ...
Amgen (AMGN) provided updates on selected product and pipeline programs, including that a Phase 1 study of AMG 513 in people living with ...
Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).
Vaxcyte has advanced to the Phase II trial’s second and final stage (Stage 2) assessing its 31-valent pneumococcal conjugate ...
Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback